Medipost Co (Medipost Co) Research & Development : $24.22 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medipost Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Medipost Co's Research & Development for the three months ended in Mar. 2024 was $6.28 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $24.22 Mil.

Medipost Co Research & Development Historical Data

The historical data trend for Medipost Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Research & Development Chart

Medipost Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Research & Development

Get a 7-Day Free Trial

8.31

10.78

8.63

9.89

14.69

Medipost Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															4.35	4.87	5.81	7.26	6.28

Medipost Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.22 Mil.

Medipost Co (OTCPK:MEPTF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medipost Co Research & Development Related Terms

Thank you for viewing the detailed overview of Medipost Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (Medipost Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (OTCPK:MEPTF) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

078160:Korea

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (Medipost Co) Headlines

No Headlines